PapersPMID:32055589
Cognition enhancing effect of panax ginseng in Korean volunteers with mild cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“In the repeated measures analysis, there were no statistically significant differences in K-MMSE and K-IADL between ginseng group and placebo group over time (P = 0.3197, P = 0.8842, ANOVA) (Table 4).”
- Study
- RCT
- Duration
- 6 months
- Dose studied
- 3.0 g per day Panax ginseng powder for 24 weeks (300 mg capsules)
- Population
- Korean adults aged 50 to 75 years with mild cognitive impairment (K-MMSE over 26 at enrolment), repeated-measures analysis across baseline, 16 and 24 weeks
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Korean volunteers aged 50 to 75 years with mild cognitive impairment (MCI), K-MMSE over 26; Panax ginseng powder (4-year-old root)
- Participants
- 90
- Comparator
- placebo
- Duration
- 168 days
- Endpoints measured
- 15